Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Larry W Kwak Michelle A Fanale Anas Younes Amanda R Copeland Sattva S Neelapu Jorge Romaguera Fredrick B Hagemeister Peter J McLaughlin Silvana de Castro Faria |
| Publication date | September 10, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |